Hui Liu

Hui Liu, Ph.D. is a seasoned biopharma executive with 25 years of experience in business development, finance, and strategy who serves as a Board Member at Rallybio.1

Professional Background

Currently, Dr. Liu holds the position of Executive Vice President, Chief Business Officer and Head of US at Merus N.V., a clinical-stage oncology company focused on developing multispecific antibody therapeutics.14

Career History

Prior to joining Merus, Hui Liu had an impressive career trajectory:

• Global Head of Business Development & Licensing at Novartis Oncology
• Global Head of Business Development and Licensing for Novartis Vaccines & Diagnostics
• Held roles of increasing responsibility in business development at Pfizer
• Worked in investment banking at Citigroup and Goldman Sachs1

Education

Dr. Liu's educational background includes:

• B.S. in biology from Peking University in Beijing, China
• M.B.A. in finance from the University of Michigan
• Ph.D. in molecular biology from the University of Michigan1

Board Appointment

Hui Liu was appointed to Rallybio's Board of Directors in April 2022, alongside Christine A. Nash.23 His extensive experience in the biopharma industry makes him a valuable addition to Rallybio's leadership team.